ENDPOINTS

Callio emerges with $187M and ADCs from a decade-old Singapore biotech

Callio emerges with $187M and ADCs from a decade-old Si...

Mar 3, 2025 0

Frazier Life Sciences and a cadre of well-known biotech investors are coming tog...

After Phase 3 depression setback, Neumora pauses two trials to make changes, scraps another

After Phase 3 depression setback, Neumora pauses two tr...

Mar 3, 2025 0

Brain health biotech Neumora has stopped two of its Phase 3 trials in major depr...

ICER finds GSK inhalers offer advantages over generics

ICER finds GSK inhalers offer advantages over generics

Mar 3, 2025 0

The higher prices of two COPD inhalers from GSK that are targeted in the second ...

Lexicon plots Phase 3 trial for diabetic pain drug despite mid-stage flop

Lexicon plots Phase 3 trial for diabetic pain drug desp...

Mar 3, 2025 0

Lexicon Pharmaceuticals’ non-opioid drug has failed a mid-stage test in a chroni...

AbbVie finally enters obesity race with $350M upfront for Gubra’s amylin

AbbVie finally enters obesity race with $350M upfront f...

Mar 3, 2025 0

One of the last big pharma holdouts in obesity has now entered what has become t...

The top 100 biotech investors; FDA vaccine meeting canceled; Can Bill Anderson save Bayer?; and more

The top 100 biotech investors; FDA vaccine meeting canc...

Mar 1, 2025 0

Good morning and rabbit rabbit as we begin the month of March. It was another bu...

At least seven drugmakers say they will participate in round two of IRA negotiations

At least seven drugmakers say they will participate in ...

Mar 1, 2025 0

More than half of drugmakers have agreed to participate in the second round of M...

At least six drugmakers say they will participate in round two of IRA negotiations

At least six drugmakers say they will participate in ro...

Feb 28, 2025 0

At least half of drugmakers have agreed to participate in the second round of Me...

Bipartisan 'pill penalty' fix and other bills vie for inclusion in reconciliation package

Bipartisan 'pill penalty' fix and other bills vie for i...

Feb 28, 2025 0

Industry groups are looking to push government drug price negotiation and PBM re...

CHMP recommends Regeneron, Novartis drugs that still await FDA approval

CHMP recommends Regeneron, Novartis drugs that still aw...

Feb 28, 2025 0

The European Medicines Agency’s human medicines committee (CHMP) has recommended...

Trump’s science crackdown hits rare disease research: ‘We need to sit down with Elon Musk’

Trump’s science crackdown hits rare disease research: ‘...

Feb 28, 2025 0

Jill Wood had pinned her hopes on a little-known federal program to fund her son...

Infectious disease doctors consider 'mini-ACIP' if RFK erodes CDC vaccine panel

Infectious disease doctors consider 'mini-ACIP' if RFK ...

Feb 28, 2025 0

Infectious disease professionals, bracing for an overhaul of the CDC's vaccine a...

Pacira absorbs GQ Bio for $32M; Layoffs at BMS, Eisai and CRISPR Therapeutics

Pacira absorbs GQ Bio for $32M; Layoffs at BMS, Eisai a...

Feb 28, 2025 0

Plus, news about Recursion, Nxera, Viatris and DualityBio: Pacira BioScience...

Praxis' essential tremor drug fails interim Phase 3 readout

Praxis' essential tremor drug fails interim Phase 3 rea...

Feb 28, 2025 0

Praxis reported that its lead small molecule program failed a Phase 3 study on F...

Pacira absorbs GQ Bio for $32M; Layoffs at Eisai and CRISPR Therapeutics

Pacira absorbs GQ Bio for $32M; Layoffs at Eisai and CR...

Feb 28, 2025 0

Plus, news about Recursion, Nxera, Viatris and DualityBio: Pacira BioScience...

BridgeBio oncology spinout to go public via combination with SPAC from Cormorant and Bihua Chen

BridgeBio oncology spinout to go public via combination...

Feb 28, 2025 0

The second blank-check vehicle from Cormorant's Bihua Chen plans to take BridgeB...

30
31
32
33
34

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.